Stochter
Profile Picture
Global Finance News 30 Jun 2026, 15:46
Strategy (MSTR) Stock Falls 7% After Analysts Cut Price Targets

Strategy (NASDAQ: MSTR) shares fell more than 7% on Tuesday after multiple Wall Street firms lowered their price targets on the Bitcoin-focused company, reflecting a more cautious near-term outlook following recent weakness in cryptocurrency prices.

TD Cowen reduced its price target to $260 from $400 while maintaining a Buy rating. Canaccord Genuity also lowered its target to $130 from $163 and reiterated its Buy recommendation. Meanwhile, Citigroup reaffirmed its Buy rating, signaling continued confidence in the company's long-term strategy despite recent market volatility.

# Lower Bitcoin Prices Pressure Sentiment

The analyst actions come as Bitcoin traded below the key $60,000 level, weighing on sentiment toward companies with significant cryptocurrency exposure.

Strategy, the largest corporate holder of Bitcoin, remains highly sensitive to movements in the digital asset's price, causing the stock to experience greater volatility than the broader equity market.

# Analysts Remain Positive on Long-Term Outlook

Although price targets were reduced, the firms largely maintained their positive ratings, suggesting the revisions reflect updated valuation assumptions rather than a deterioration in Strategy's underlying investment thesis.

Analysts continue to view the company's substantial Bitcoin holdings as a long-term source of value but acknowledge that near-term performance will likely remain closely tied to cryptocurrency market conditions.

# Why MSTR Stock Is Falling

Several factors weighed on shares:

* TD Cowen lowered its price target to $260 from $400.
* Canaccord Genuity reduced its target to $130 from $163.
* Bitcoin remained under pressure, trading below $60,000.
* Investors continued to reduce exposure to cryptocurrency-related equities.

The combination of lower analyst price targets and ongoing weakness in Bitcoin contributed to the roughly 7% decline in Strategy shares, even as most analysts maintained bullish ratings on the stock.

Comments

No comments yet.